Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hynes

Showing results (221-230 of 275) with videos related to

Pageof 28
Sort By:
Cancer Research|November 1, 1990
Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cellsC Marth, E Müller-Holzner, E Greiter, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
American Journal of Clinical Oncology|August 1, 1993
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group studyW S Fletcher, D S Daniels, V K Sondak, et al.
The EMBO Journal|January 15, 1996
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancerD Karunagaran, E Tzahar, R R Beerli, et al.
Investigational New Drugs|May 1, 1990
5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group studyJ T Guy, T Fleming, T W Pollock, et al.
Oncogene|August 3, 2000
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesisL Yen, X L You, A E Al Moustafa, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
International Journal of Cancer|January 3, 1995
EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteinsW Wels, R Beerli, P Hellmann, et al.
Cancer Treatment and Research|January 1, 1988
Identification of oncogenes in breast tumors and their effects on growth and differentiationB Groner, N E Hynes, S Kozma, et al.
The EMBO Journal|May 13, 2005
Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoliNa Li, Yu Zhang, Matthew J Naylor, et al.
Pageof 28

Showing results (221-230 of 275) with videos related to

Sort By:
Pageof 28
Cancer Research|November 1, 1990
Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cellsC Marth, E Müller-Holzner, E Greiter, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
American Journal of Clinical Oncology|August 1, 1993
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group studyW S Fletcher, D S Daniels, V K Sondak, et al.
The EMBO Journal|January 15, 1996
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancerD Karunagaran, E Tzahar, R R Beerli, et al.
Investigational New Drugs|May 1, 1990
5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group studyJ T Guy, T Fleming, T W Pollock, et al.
Oncogene|August 3, 2000
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesisL Yen, X L You, A E Al Moustafa, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
International Journal of Cancer|January 3, 1995
EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteinsW Wels, R Beerli, P Hellmann, et al.
Cancer Treatment and Research|January 1, 1988
Identification of oncogenes in breast tumors and their effects on growth and differentiationB Groner, N E Hynes, S Kozma, et al.
The EMBO Journal|May 13, 2005
Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoliNa Li, Yu Zhang, Matthew J Naylor, et al.
Pageof 28